News Releases

Moffitt Cancer Center and Natera Launch Research Collaboration on MRD-Guided Precision Medicine

Collaboration will study how blood-based molecular testing with Natera’s Signatera test can help guide treatment and improve patient outcomes across...

Moffitt Cancer Center Opens Discovery And Innovation Center At Speros

New research facility strengthens convergent campus, bringing approximately 250 researchers and staff to Speros to advance cell therapies,...

Moffitt Cancer Center Earns 2026 Digital Health Most Wired Recognition

Cancer center receives Level 7 recognition in acute and ambulatory care for its continued use of technology to enhance patient care and operations

Moffitt Researchers Find Ways to Improve How a T Cell Fights Cancer

Study identifies ways to boost the performance and persistence of engineered immune cells, potentially improving treatments for cancers that spread...

Moffitt Researchers Identify ‘Goliath’ Cell Groups That Could Help Explain How Skin Cancer Begins

Study suggests unusually large groups of skin cells may develop before cancer-driving mutations, offering new insights into the earliest stages of...

Moffitt Advances Patient Avatar Technologies Through $15 Million Federal Research Initiative

Scientists will use microtumor and microtissue models to advance cancer research, personalized medicine and pandemic preparedness

Moffitt Names Three Technology Leaders to the Melanoma and Skin Cancer Center of Excellence Board of Advisers

Ming Hsieh, Stan Lapidus and Don Listwin bring expertise in technology, entrepreneurship and early cancer detection

Moffitt Cancer Center, Thomas Jefferson University Receive $2.8 Million to Advance Acral Melanoma Research

Collaborative project will investigate new immune and targeted treatment strategies for a rare and difficult-to-treat form of melanoma

New Treatment Scheduling Strategy May Help Cancer Drugs Stay Effective Longer

Dosing strategy aims to slow drug resistance by changing how treatments are scheduled

Moffitt Cancer Center Launches Radiopharma Program to Accelerate Research, Clinical Translation, and Manufacturing of Next Generation Cancer Treatment

New interdisciplinary program will bring together clinical, research and operational expertise to position Speros as a Southeastern hub for...

Moffitt Researchers Develop Mathematical Measures to Better Personalize Therapy for Prostate Cancer

New approach using routine PSA information may help identify patients most likely to benefit from treatment breaks

New Moffitt Study Offers Clues to Why TIL Immunotherapy Works for Some Melanoma Patients but Not Others

Findings reveal immune cell and tumor characteristics that could help researchers improve tumor-infiltrating lymphocyte therapy and identify patients...

Moffitt Scientists Pioneer Next Generation Covalent Chemistry to Build Safer Precision Medicines

New chemistry helps experimental cancer drugs target tumors more precisely while reducing unwanted interactions in preclinical studies

Moffitt Cancer Center Announces Research Alliance With Takeda To Advance Cancer Therapies

New collaboration aims to expand clinical and translational research in blood cancers and solid tumors

Moffitt Study Identifies Protein that Helps Eye Cancer Spread to the Liver

Protein alters liver cells and blood vessel growth, creating a foothold for metastasis